These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12021539

  • 1. Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.
    Navascués RA, Gómez E, Rodriguez M, Laures AS, Baltar J, Grande JA.
    Nephron; 2002 May; 91(1):173-4. PubMed ID: 12021539
    [No Abstract] [Full Text] [Related]

  • 2. Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout.
    Jacobs F, Mamzer-Bruneel MF, Skhiri H, Thervet E, Legendre C, Kreis H.
    Transplantation; 1997 Oct 15; 64(7):1087-8. PubMed ID: 9381537
    [No Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM, Donadi MO, Oliveira ML, Ponte CN, Pinheiro PM.
    Transplant Proc; 1999 Nov 15; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients.
    Keunecke C, Rothenpieler U, Zanker B, Schneeberger H, Illner WD, Theodorakis J, Stangl M, Land W.
    Transplant Proc; 2000 Feb 15; 32(1A Suppl):6S-8S. PubMed ID: 10686310
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil in cyclosporine-associated nephrotoxicity.
    Ducloux D, Fournier V, Bresson-Vautrin C, Rebibou JM, Saint-Hillier Y, Chalopin JM.
    Transplant Proc; 1998 Sep 15; 30(6):2825-7. PubMed ID: 9745583
    [No Abstract] [Full Text] [Related]

  • 6. Use of mycophenolate mofetil in renal transplant patients with cyclosporin toxicity.
    Shaheen FA, Sheikh IA.
    Transplant Proc; 1999 Dec 15; 31(8):3294. PubMed ID: 10616481
    [No Abstract] [Full Text] [Related]

  • 7. Influence of serum uric acid levels in response to the conversion from mycophenolate mofetil to mizoribine in kidney transplant recipients.
    Ding X, Zhu X, Zhang Y, Zhang L, Cheng M, Yu Y, Xu L, Li G.
    Transplant Proc; 2013 Dec 15; 45(1):190-3. PubMed ID: 23375297
    [Abstract] [Full Text] [Related]

  • 8. Use of mycophenolate mofetil in patients with chronic cyclosporine nephrotoxicity.
    Wombolt DG, McCune TR, Stewart M.
    Transplant Proc; 1998 Jun 15; 30(4):1194. PubMed ID: 9636483
    [No Abstract] [Full Text] [Related]

  • 9. Contribution of mycophenolate mofetil after withdrawal of cyclosporine to toxicity in kidney transplantation.
    Hazzan M, Bourdon F, Dracon M, Lelièvre G, Noël C.
    Transplant Proc; 1998 Sep 15; 30(6):2809-10. PubMed ID: 9745575
    [No Abstract] [Full Text] [Related]

  • 10. Tolerance of mycophenolate mofetil is dependent on kidney function.
    Puggia R, Rizzolo M, Maresca MC, Calconi G, Vianello A.
    Transplant Proc; 1998 Aug 15; 30(5):2228. PubMed ID: 9723450
    [No Abstract] [Full Text] [Related]

  • 11. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
    Taheri M, Pourmand G, Mehrsai AR, Mansoori D.
    Transplant Proc; 2003 Nov 15; 35(7):2752-3. PubMed ID: 14612105
    [No Abstract] [Full Text] [Related]

  • 12. [Mycophenolate mofetil in comparison with other immunosuppressive drugs].
    Schnülle P, van der Woude FJ.
    Internist (Berl); 1998 Aug 15; 39(8):879-86. PubMed ID: 9757398
    [No Abstract] [Full Text] [Related]

  • 13. Treatment with mycophenolate mofetil in long-term renal transplant recipients: single-center experience in 28 patients.
    Djeffal R, Hiesse C, Kriaa F, Hafi A, Boubenider S, Ammor M, Durrbach A, Von Ey F, Droupy S, Hammoudi Y, Eschwege P, Benoît G, Charpentier B.
    Transplant Proc; 2000 Dec 15; 32(8):2765-6. PubMed ID: 11134792
    [No Abstract] [Full Text] [Related]

  • 14. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
    Sánchez V, Delgado JF, Blasco T, Dalmau R, Morales JM, Escribano P, Tello R, Hernández J, Velázquez T, Sotelo T, Gómez-Sánchez MA, Sáenz de la Calzada C.
    Transplant Proc; 1999 Sep 15; 31(6):2515-6. PubMed ID: 10500695
    [No Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity.
    Torras J, Figueras J, Lama C, Fabregat J, Ramos E, Rafecas A, Gil-Vernet S, Pares D, Busquets J, Jaurrieta E.
    Transplant Proc; 1999 Sep 15; 31(6):2430. PubMed ID: 10500656
    [No Abstract] [Full Text] [Related]

  • 16. Use of mycophenolate mofetil in kidney transplant recipients with viral hepatitis infection: is it justified?
    Sumethkul V, Ingsathit A, Leelasa-Nguan P, Jirasiritham S.
    Transplant Proc; 2002 Dec 15; 34(8):3217-9. PubMed ID: 12493425
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M, Hachicha J, Bahloul Z, Kaddour N, Kharrat M, Jarraya F, Jarraya A.
    Transplant Proc; 1995 Oct 15; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients.
    Land W, Schneeberger H, Weiss M, Ege T, Stümpfig L.
    Transplant Proc; 2001 Jun 15; 33(4 Suppl):29S-35S. PubMed ID: 11406265
    [No Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil-induced hyperbilirubinemia in renal transplant recipients.
    Chueh SC, Huang CY, Lai MK.
    Transplant Proc; 2000 Nov 15; 32(7):1901-2. PubMed ID: 11119992
    [No Abstract] [Full Text] [Related]

  • 20. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
    Zawiasa A, Szklarek-Kubicka M, Fijałkowska-Morawska J, Nowak D, Rysz J, Mamełka B, Nowicki M.
    Transplant Proc; 2009 Nov 15; 41(1):188-91. PubMed ID: 19249511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.